Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of Kudancao in use for resisting lung fibrosis

A technology for pulmonary fibrosis and Bilbus vulgaris, which is applied to medical preparations containing active ingredients, medical raw materials from angiosperm subphylum, plant raw materials, etc., to achieve good pharmacological effects, good resistance to pulmonary fibrosis, and reduction of pulmonary fibrosis degree of effect

Active Publication Date: 2006-12-06
云南云河药业股份有限公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For SARS patients, give full play to the strengths of traditional Chinese medicine, especially the geographical advantages of Yunnan traditional Chinese medicine, and use the traditional Chinese medicine of Esplethys chinensis with a large number of clinical applications to conduct research on the pharmacological effects of anti-pulmonary fibrosis, with the goal of relieving the disease, controlling symptoms and reducing mortality , there is no in-depth research and exploration

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Kudancao in use for resisting lung fibrosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0009] (1) Anti-BLMA of the present invention 5 Induced pulmonary fibrosis in rats

[0010] Bleomycin A 5 (Bleomycin A 5 , BLMA 5 ) induced pulmonary fibrosis animal model of lung histopathology and physiological changes similar to human pulmonary fibrosis. When the number of fibroblasts increases, the production of type I collagen increases significantly, resulting in an imbalance between type I and type III collagen, resulting in collagen deposition and pulmonary fibrosis.

[0011] The experimental, healthy Kunming SD rats with a body weight of 180-200g were randomly divided into normal control group, normal saline group and BLMA group. 5 group and Echinacea group. Among them, BLMA 5 In the group, 20% urethane was injected intraperitoneally with 100mg / 100g of body weight, and under aseptic conditions, the skin in the middle of the neck was cut about 0.5cm long, and a 1ml sterile syringe was inserted into the trachea, and 0.5ml / 100g of body weight ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An application of the scabrous elephantfoot herb in treating the hepatofibrosis of SARS patient is disclosed.

Description

Technical field [0001] The invention belongs to pharmaceutical preparations containing organic active ingredients. Background technique [0002] Severe Acute Respiratory Syndrome, or SARS, is an acute infectious disease with the respiratory tract as the main transmission route, rapid disease progression and high fatality rate. The lung histopathology of dead patients with SARS showed diffuse pulmonary congestion and hemorrhage of different development levels and severity, alveolar damage, hyaline membrane formation, exfoliation of alveolar cells into the cavity, fibrinous necrosis of pulmonary small blood vessels, interstitial Inflammatory infiltration of monocytes in the cytoplasm and pulmonary fibrosis and other lesions (Yan KV, Chan JK. Image in pathology: pulmonary pathology of severe acute respiratory syndrome. Int. J Surg Pathol. 2003; 11: 118-126.). The pathological changes of SARS patients in the late stage of the disease are consi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/74A61K36/27A61K36/19A61K9/20A61K9/12A61P11/00
Inventor 王殿华张旋张恒丽张洁薛凤麟雷伟亚张荣平
Owner 云南云河药业股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com